Showing results (2181-2190 of 2,409) with videos related to

Sort By:
Pageof 241
Transplantation|June 9, 2017
DHRS9 Is a Stable Marker of Human Regulatory MacrophagesPaloma Riquelme, Giada Amodio, Camila Macedo, et al.
RMD Open|November 14, 2020
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature researchAndreas Kerschbaumer, Josef S Smolen, Peter Nash, et al.
Plos One|July 11, 2013
Extensive variation in gene copy number at the killer immunoglobulin-like receptor locus in humansSanne Vendelbosch, Martin de Boer, Remko A T W Gouw, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 7, 2013
Unconventional RORγt+ T cells drive hepatic ischemia reperfusion injuryElke Eggenhofer, Jordi Rovira, Manije Sabet-Baktach, et al.
Leukemia & Lymphoma|August 1, 2002
Serum tryptase measurements in patients with myelodysplastic syndromesW R Sperr, B Stehberger, F Wimazal, et al.
International Journal of Cancer|December 23, 2014
NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumorsChristoph Schulz, Frank Kullmann, Volker Kunzmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2007
Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancerS Boeck, T Hoehler, G Seipelt, et al.
Blood|September 16, 2011
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphomaBoris Böll, Henning Bredenfeld, Helen Görgen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2013
Regulation of Son of sevenless by the membrane-actin linker protein ezrinKatja J Geissler, M Juliane Jung, Lars Björn Riecken, et al.
Alzheimer'S Research & Therapy|November 15, 2020
Targeting isoaspartate-modified Aβ rescues behavioral deficits in transgenic mice with Alzheimer's disease-like pathologyKathrin Gnoth, Anke Piechotta, Martin Kleinschmidt, et al.
Pageof 241